Manejo de la queratopatía neurotrófica mediante tarsorrafia con cianocrilato y suero autólogo
- D Díaz-Valle
- JM Benítez del Castillo Sánchez
- E Díaz Rodríguez
- N Toledano Fernández
- A Arteaga Sánchez
- O Sayagués Gómez
ISSN: 0365-6691
Year of publication: 2003
Volume: 78
Issue: 2
Pages: 119-122
Type: Article
More publications in: Archivos de la Sociedad Española de Oftalmologia
Abstract
Purpose/Methods: Neurotrophic keratopathy is a degenerative corneal disease with a highly complex treatment caused by an impairment of corneal sensitivity. We report the case of a 47 year-old man with a refractory postherpetic neurotrophic keratopathy in his right eye and we discuss the treatment options. Results/Conclusion: The combination of cyanoacrylate with temporary tarsorraphy along with the administration of topical autologous serum eyedrops and systemic tetracycline, allowed to control the progression of the disease and to regenerate the corneal surface. This unpublished therapeutic strategy might be an effective and safe alternative in the management of neurotrophic keratopathy. (Arch Soc Esp Oftalmol 2003; 78: 119-122).
Bibliographic References
- Gross, EB Jr. (1997). Cornea: Fundamentals of Corneal and External Disease. Mosby. St. Louis.
- Heigle, TJ, Pflugfelder, SC. (1996). Aqueous tear production in patients with neurotrophic keratopathy. Cornea. 15. 135-138
- Lambiasse, A, Rama, P, Aloe, L, Bonini, S. (1999). Management of neurotrophic keratopathy. Curr Opin Ophthalmol. 10. 270-276
- Poon, AC, Geerling, G, Dart, JK, Fraenkel, GE, Daniels, JT. (2001). Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vivo toxicity studies. Br J Ophthalmol. 85. 1188-1197
- Perry, HD, Kenyon, KR, Lamberts, DW, Foulks, GN, Seedor, JA, Golub, LM. (1986). Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial defect. Ophthalmology. 93. 1320-1322